Department of Anesthesiology, Habib Bourguiba University Hospital, Sfax, Tunisia.
Department of Abdominal Surgery, Habib Bourguiba University Hospital, Sfax, Tunisia.
Pan Afr Med J. 2024 May 24;48:18. doi: 10.11604/pamj.2024.48.18.40317. eCollection 2024.
postoperative sore throat (POST) is a common complication after general anesthesia with endotracheal intubation caused by tracheal mucosal injury. Multiple techniques prevent postoperative sore throat (POST). Our study aimed to compare two techniques: intravenous and intracuff lidocaine versus placebo to prevent postoperative sore throat after general anesthesia with orotracheal intubation.
we conducted a prospective double-blind, randomized controlled clinical trial involving patients, proposed for a scheduled surgery less than 240 minutes under general anesthesia with orotracheal intubation. Patients were divided into three groups: L group: infused with saline, cuff filled with alkalinized lidocaine. S group: Infused with 1.5 mg/kg of lidocaine, cuff filled with saline. T group: placebo: infused with saline, cuff filled with saline. Our primary outcome was the incidence of sore throat and their (visual analog scale) VAS score in the first 24 postoperative hours. Our secondary outcomes were the incidence of cough, dysphonia, dysphagia, and postoperative nausea and vomiting.
ninety patients were analyzed and divided into 3 groups of 30. The incidence of POST at the sixth postoperative hour, for placebo, the "L" group, and the "S" group, respectively, was 67%, 30%, and 47%. And at the 24 postoperative hours 67%, 13%, and 37%. Intravenous lidocaine reduced significantly the VAS of POST at the 24 hour (S: 6.80 ± 20.70; T: 20.67 ± 18.182; p= 0.02). Alkalinized lidocaine decreased significantly the VAS of POST in the sixth (L: 8.17 ± 22.761; T: 23 ± 21.838; p = 0.048) and the 24 postoperative hour (L: 6.33 ± 20.592; T: 20.67 ± 18.182; p= 0.019) with the lowest pain score. There was no statistically significant difference between the L and S groups at the 6 and 24 postoperative hours. Both lidocaine techniques reduced cough at emergence, with the superiority of alkalinized lidocaine (p=0.02). They decreased the incidence of cough, dysphonia, dysphagia, nausea, and vomiting compared to a placebo.
intravenous and intracuff lidocaine allowed better control of postoperative sore throat.
术后咽喉痛(POST)是全身麻醉气管插管后常见的并发症,是由气管黏膜损伤引起的。多种技术可预防术后咽喉痛(POST)。我们的研究旨在比较两种技术:静脉内和气管内利多卡因与安慰剂,以预防全身麻醉下经口气管插管后的术后咽喉痛。
我们进行了一项前瞻性、双盲、随机对照临床试验,涉及拟行手术时间少于 240 分钟的患者,全身麻醉下经口气管插管。患者分为三组:L 组:输注生理盐水,气管内套囊内填充碱性利多卡因。S 组:输注 1.5mg/kg 利多卡因,气管内套囊内填充生理盐水。T 组:安慰剂:输注生理盐水,气管内套囊内填充生理盐水。我们的主要结局是术后 24 小时内咽喉痛的发生率及其(视觉模拟评分)VAS 评分。我们的次要结局是咳嗽、声音嘶哑、吞咽困难和术后恶心呕吐的发生率。
分析了 90 例患者,并将其分为 3 组,每组 30 例。术后 6 小时、安慰剂组、“L”组和“S”组的 POST 发生率分别为 67%、30%和 47%。术后 24 小时,67%、13%和 37%。静脉内利多卡因可显著降低术后 24 小时的 POST VAS(S:6.80±20.70;T:20.67±18.182;p=0.02)。碱性利多卡因可显著降低术后 6 小时(L:8.17±22.761;T:23±21.838;p=0.048)和 24 小时(L:6.33±20.592;T:20.67±18.182;p=0.019)的 POST VAS,疼痛评分最低。L 组和 S 组在术后 6 小时和 24 小时的差异无统计学意义。两种利多卡因技术均可降低苏醒时的咳嗽发生率,碱性利多卡因具有优势(p=0.02)。与安慰剂相比,它们可降低咳嗽、声音嘶哑、吞咽困难、恶心和呕吐的发生率。
静脉内和气管内利多卡因可更好地控制术后咽喉痛。